Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Oct 1;184(4):1513-8.
doi: 10.1084/jem.184.4.1513.

Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain

Affiliations

Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain

P Dowling et al. J Exp Med. .

Abstract

Immunohistochemical methods were used to search for Fas receptor/Fas ligand system involvement in multiple sclerosis (MS) white matter brain lesions. We found large numbers of Fas ligand (Fas-L)-bearing cells present in two acute lesions and 12 of 16 chronic MS lesions, and very few positive cells in non-inflammatory controls. Four of six brains from non-MS neuropathologic conditions associated with inflammation and white matter disease were, however, also positive for Fas-L. Double staining with cell-specific markers revealed that the pattern of ligand-positive cells in chronic MS lesions was complex and composed of several different cell types which were primarily resident glial cells with a small overlay of macrophages. Fas/APO 1 (CD95) receptor expression in MS tissue was also evaluated and marked upregulation of the receptor was found. In addition, Fas receptor was induced, but to a lesser extent, in numerous control brains. The observations that TUNEL-positive dying cells were present in MS lesions and showed excellent co-localization with Fas-L, indicate that the Fas death system may contribute to plaque pathogenesis and could lead to the development of a new category of therapeutic agents for MS.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Science. 1995 Nov 17;270(5239):1189-92 - PubMed
    1. Immunol Rev. 1995 Apr;144:75-107 - PubMed
    1. Brain Res. 1995 Oct 16;695(2):137-45 - PubMed
    1. Nat Med. 1996 Mar;2(3):317-22 - PubMed
    1. Nature. 1996 Apr 25;380(6576):723-6 - PubMed

Publication types